Invention Grant
- Patent Title: RSV-specific binding molecules and means for producing them
-
Application No.: US14026182Application Date: 2013-09-13
-
Publication No.: US09321831B2Publication Date: 2016-04-26
- Inventor: Hergen Spits , Tim Beaumont , Mark Jeroen Kwakkenbos , Etsuko Yasuda
- Applicant: MedImmune Limited
- Applicant Address: GB Cambridge
- Assignee: MedImmune Limited
- Current Assignee: MedImmune Limited
- Current Assignee Address: GB Cambridge
- Agency: Mueting, Raasch & Gebhardt, P.A.
- Priority: EP07109472 20070601
- Main IPC: C07K16/10
- IPC: C07K16/10 ; A61K39/12 ; A61K39/00
Abstract:
The invention provides antibodies and functional equivalents thereof which are capable of specifically binding RSV, and means and methods for producing them.
Public/Granted literature
- US20140377279A9 RSV-SPECIFIC BINDING MOLECULES AND MEANS FOR PRODUCING THEM Public/Granted day:2014-12-25
Information query
